Portfolio company
Aranda Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops small molecule inhibitors for patients suffering from hair loss, acne and brain diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pelage
This company develops regenerative topical medicines to treat hair loss for individuals with androgenetic alopecia and other forms of hair thinning.
Augustine Therapeutics
This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.
Fundamental Pharma
This biopharmaceutical company develops small molecule inhibitors for patients suffering from treatment-resistant depression and neurodegenerative diseases such as amyotrophic lateral sclerosis.
NMD Pharma
This company develops small molecule therapies for patients suffering from severe neuromuscular disorders to restore skeletal muscle function.
DAMONA Pharmaceuticals
This company develops small molecule therapeutics to restore cognitive function for patients with neurological and psychiatric disorders.
ARase Therapeutics
This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.
Flindr Therapeutics
This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.
Coegin pharma
This biotechnology company develops peptide-based cosmetic products for hair growth and skin pigmentation, targeting individuals seeking solutions for hair thinning and skin longevity.
